# Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment

> **NCT01704001** · PHASE4 · COMPLETED · sponsor: **Asahi Kasei Therapeutics Corporation** · enrollment: 40 (estimated)

## Conditions studied

- Disseminated Intravascular Coagulation

## Interventions

- **DRUG:** ART-123

## Key facts

- **NCT ID:** NCT01704001
- **Lead sponsor:** Asahi Kasei Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2014-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704001, "Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01704001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*